Article
Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data.
PloS one - 1 Jan 2013
Kumar Runjun D, Chang Li-Wei, Ellis Matthew J, Bose Ron
Abstract excerpt
A major goal of cancer genome sequencing is to identify mutations or other somatic alterations that can be targeted by selective and specific drugs. dGene is an annotation tool designed to rapidly identify genes belonging to one of ten druggable classes that are frequently targeted in cancer drug development. These classes were comprehensively populated by combining and manually curating data from multiple...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
